Literature DB >> 23849793

The papillomavirus E2 proteins.

Alison A McBride1.   

Abstract

The papillomavirus E2 proteins are pivotal to the viral life cycle and have well characterized functions in transcriptional regulation, initiation of DNA replication and partitioning the viral genome. The E2 proteins also function in vegetative DNA replication, post-transcriptional processes and possibly packaging. This review describes structural and functional aspects of the E2 proteins and their binding sites on the viral genome. It is intended to be a reference guide to this viral protein. Published by Elsevier Inc.

Entities:  

Keywords:  E2; Genomics; HPV; Mutation; Papillomavirus; Replication; Structure; Tethering; Transcription

Mesh:

Substances:

Year:  2013        PMID: 23849793      PMCID: PMC3783563          DOI: 10.1016/j.virol.2013.06.006

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  261 in total

1.  Conserved cysteine residue in the DNA-binding domain of the bovine papillomavirus type 1 E2 protein confers redox regulation of the DNA-binding activity in vitro.

Authors:  A A McBride; R D Klausner; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

2.  Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator.

Authors:  Noor Gammoh; Helena Sterlinko Grm; Paola Massimi; Lawrence Banks
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Recruitment and loading of the E1 initiator protein: an ATP-dependent process catalysed by a transcription factor.

Authors:  C M Sanders; A Stenlund
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

4.  Segregation of viral plasmids depends on tethering to chromosomes and is regulated by phosphorylation.

Authors:  C W Lehman; M R Botchan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

5.  Influence of HPV16 E2 and its localisation on the expression of matrix metalloproteinase-9.

Authors:  Sabrina Mühlen; Andreas Behren; Thomas Iftner; Christian Simon
Journal:  Int J Oncol       Date:  2010-08       Impact factor: 5.650

6.  Transcriptional silencer of the human papillomavirus type 8 late promoter interacts alternatively with the viral trans activator E2 or with a cellular factor.

Authors:  M May; K Grassmann; H Pfister; P G Fuchs
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

7.  The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.

Authors:  S H Tan; L E Leong; P A Walker; H U Bernard
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  Human papillomavirus E2 down-regulates the human telomerase reverse transcriptase promoter.

Authors:  Daeyoup Lee; Hak-Zoo Kim; Kwi Wan Jeong; Young Sam Shim; Izumi Horikawa; J Carl Barrett; Joonho Choe
Journal:  J Biol Chem       Date:  2002-05-17       Impact factor: 5.157

9.  Interaction of the betapapillomavirus E2 tethering protein with mitotic chromosomes.

Authors:  Vandana Sekhar; Shawna C Reed; Alison A McBride
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

10.  The interaction between human papillomavirus type 16 E1 and E2 proteins is blocked by an antibody to the N-terminal region of E2.

Authors:  M H Hibma; K Raj; S J Ely; M Stanley; L Crawford
Journal:  Eur J Biochem       Date:  1995-04-15
View more
  155 in total

1.  Human Papillomavirus 16 E2 Regulates Keratinocyte Gene Expression Relevant to Cancer and the Viral Life Cycle.

Authors:  Michael R Evans; Claire D James; Molly L Bristol; Tara J Nulton; Xu Wang; Namsimar Kaur; Elizabeth A White; Brad Windle; Iain M Morgan
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing.

Authors:  Soniya Dhanjal; Naoko Kajitani; Jacob Glahder; Ann-Kristin Mossberg; Cecilia Johansson; Stefan Schwartz
Journal:  J Biol Chem       Date:  2015-04-15       Impact factor: 5.157

3.  Phosphorylation of the Human Papillomavirus E2 Protein at Tyrosine 138 Regulates Episomal Replication.

Authors:  Leny Jose; Elliot J Androphy; Marsha DeSmet
Journal:  J Virol       Date:  2020-07-01       Impact factor: 5.103

4.  Papillomavirus E2 protein is regulated by specific fibroblast growth factor receptors.

Authors:  Marsha DeSmet; Sriramana Kanginakudru; Leny Jose; Fang Xie; Timra Gilson; Elliot J Androphy
Journal:  Virology       Date:  2018-06-06       Impact factor: 3.616

Review 5.  Human papillomavirus molecular biology.

Authors:  Mallory E Harden; Karl Munger
Journal:  Mutat Res Rev Mutat Res       Date:  2016-07-05       Impact factor: 5.657

6.  The SMC5/6 Complex Interacts with the Papillomavirus E2 Protein and Influences Maintenance of Viral Episomal DNA.

Authors:  Peris Bentley; Min Jie Alvin Tan; Alison A McBride; Elizabeth A White; Peter M Howley
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

7.  Human Papillomavirus 31 Tyrosine 102 Regulates Interaction with E2 Binding Partners and Episomal Maintenance.

Authors:  Timra Gilson; Sara Culleton; Fang Xie; Marsha DeSmet; Elliot J Androphy
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

Review 8.  Human Papillomavirus E2 Protein: Linking Replication, Transcription, and RNA Processing.

Authors:  Sheila V Graham
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 9.  Immune therapy for human papillomaviruses-related cancers.

Authors:  Ricardo Rosales; Carlos Rosales
Journal:  World J Clin Oncol       Date:  2014-12-10

Review 10.  Involvement of Brd4 in different steps of the papillomavirus life cycle.

Authors:  Thomas Iftner; Juliane Haedicke-Jarboui; Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  Virus Res       Date:  2016-12-10       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.